Report cover image

Empty Capsules

Published May 01, 2026
Length 256 Pages
SKU # GJOB21160726

Description

REPORT HIGHLIGHTS

Global Empty Capsules Market to Reach US$5.8 Billion by 2032

The global market for Empty Capsules estimated at US$3.6 Billion in the year 2025, is expected to reach US$5.8 Billion by 2032, growing at a CAGR of 7.2% over the analysis period 2025-2032. Gelatin Capsules Product Type, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Non-Gelatin Capsules Product Type segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 7.0% CAGR

The Empty Capsules market in the U.S. is estimated at US$1.1 Billion in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2032 trailing a CAGR of 7.0% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.9% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Empty Capsules Market - Key Trends and Drivers Summarized

How Are Empty Capsules Revolutionizing Pharmaceutical and Nutraceutical Industries?

Empty capsules are revolutionizing the pharmaceutical and nutraceutical industries by providing a versatile, customizable, and efficient delivery method for a wide range of active ingredients. These capsules, which can be filled with powders, granules, liquids, or even semi-solids, are essential for the production of medications, dietary supplements, and herbal products. They offer an ideal solution for encapsulating compounds that may be sensitive to light, moisture, or air, ensuring the stability and effectiveness of the active ingredients. Empty capsules also provide significant advantages in terms of dosage accuracy, ease of use, and patient compliance, particularly for individuals who have difficulty swallowing tablets. The ability to customize the size, color, and composition of capsules allows manufacturers to create tailored products that meet specific therapeutic or dietary needs, enhancing both the effectiveness and appeal of the final product. As demand for personalized medicine and health supplements continues to grow, empty capsules are becoming increasingly important in the development and delivery of innovative health solutions.

What Innovations Are Enhancing the Functionality of Empty Capsules?

Innovations in the production and design of empty capsules are enhancing their functionality through advancements in materials, manufacturing processes, and customization options. One of the most significant developments is the introduction of plant-based and vegetarian capsules made from materials such as hydroxypropyl methylcellulose (HPMC) and pullulan. These capsules offer a viable alternative to traditional gelatin capsules, which are derived from animal sources, making them suitable for vegetarians, vegans, and individuals with dietary restrictions. These plant-based capsules also provide better stability for encapsulating sensitive ingredients and are less prone to cross-linking, which can affect the release and absorption of the active compounds. Another key innovation is the use of advanced manufacturing techniques that allow for the production of capsules with enhanced features, such as enteric coatings that protect the contents from stomach acid and ensure targeted delivery in the intestines. Additionally, the development of flavored and scented capsules is improving the sensory experience for consumers, making it easier for individuals to take their medications or supplements. Customization options have also expanded, with manufacturers now offering a wide range of capsule sizes, colors, and printing capabilities, enabling the creation of distinctive, branded products that stand out in the market. These innovations are making empty capsules more adaptable, effective, and consumer-friendly, driving their adoption across a broad spectrum of health products.

How Do Empty Capsules Impact Product Development and Consumer Compliance?

Empty capsules have a significant impact on product development and consumer compliance by providing a flexible and user-friendly dosage form that enhances the delivery and effectiveness of active ingredients. For product developers, capsules offer a convenient and efficient way to formulate and deliver a wide variety of compounds, including those that are difficult to compress into tablets or that require protection from environmental factors. The versatility of capsules allows manufacturers to experiment with different formulations, such as combining multiple ingredients or creating delayed-release products, without the need for complex manufacturing processes. This flexibility is particularly valuable in the nutraceutical industry, where the demand for innovative, multi-ingredient supplements is high. From the consumer’s perspective, capsules are often preferred over tablets due to their ease of swallowing and lack of unpleasant taste or odor. This preference can lead to better adherence to prescribed regimens or supplement routines, improving the likelihood of achieving the desired health outcomes. Moreover, the ability to produce capsules in various sizes and with different release profiles allows healthcare providers to tailor treatments to individual needs, further enhancing compliance and effectiveness. By offering a dosage form that is both adaptable and consumer-friendly, empty capsules play a crucial role in the development of successful health products and in promoting better patient outcomes.

What Trends Are Driving Growth in the Empty Capsules Market?

Several trends are driving growth in the empty capsules market, including the increasing demand for plant-based and clean-label products, the rise of personalized medicine, and the expansion of the nutraceutical sector. As consumers become more health-conscious and environmentally aware, there is a growing preference for plant-based capsules that align with vegan, vegetarian, and clean-label requirements. This shift is prompting capsule manufacturers to innovate with alternative materials that offer the same benefits as traditional gelatin capsules while meeting the needs of a broader consumer base. The rise of personalized medicine, where treatments are tailored to individual genetic profiles and health conditions, is also contributing to market growth. Empty capsules are ideal for creating customized medications and supplements, as they allow for precise dosing and the combination of multiple active ingredients in a single, easy-to-swallow form. Additionally, the expanding nutraceutical sector, driven by increased interest in preventive health and wellness, is fueling demand for capsules as a preferred delivery method for vitamins, minerals, herbal extracts, and other dietary supplements. The convenience, versatility, and consumer appeal of capsules make them a natural choice for nutraceutical companies looking to differentiate their products in a competitive market. These trends underscore the growing importance of empty capsules in the pharmaceutical and nutraceutical industries, as they continue to play a key role in meeting evolving consumer demands and supporting the development of innovative health products.

SCOPE OF STUDY:

The report analyzes the Empty Capsules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Gelatin Capsules Product Type, Non-Gelatin Capsules Product Type); Source (Animal-based Source, Plant & Fermentation-based Source); Functionality (Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality, Other Functionalities); Application (Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

SELECT PLAYERS -
  • ACG
  • Beeline Healthcare Ltd.
  • Bio Caps India Ltd.
  • Capscanada Corporation
  • Capsugel, Inc.
  • Comed Chemicals Ltd.
  • DM Pharma Marketing Pvt Ltd.
  • Erawat Pharma Ltd.
  • EuCaps
  • SaintyCo
  • Yasin
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table of Contents

256 Pages
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
Empty Capsules – Global Key Competitors Percentage Market Share in 2026 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Expansion of the Nutraceutical Industry Drives Demand for Empty Capsules
Growth in Global Pharmaceutical Manufacturing Bolsters Market for Capsules
Market Trends Toward Vegetarian and Clean-label Capsule Solutions
Development of Fast-dissolving and Targeted Release Capsules Sets the Stage for Advanced Applications
Consumer Preferences Shifting Towards Non-animal Derived Capsule Ingredients
Integration of Capsule Technologies in Personalized Medicine
Global Expansion of Generic Drug Markets Impacting Capsule Demand
Technological Advances in Capsule Filling and Sealing Equipment
Innovations in Biodegradable and Sustainable Capsule Materials
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 2: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 3: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 4: World Empty Capsules Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
TABLE 5: World Recent Past, Current & Future Analysis for Empty Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 6: World Historic Review for Empty Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 7: World 13-Year Perspective for Empty Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
TABLE 8: World Recent Past, Current & Future Analysis for Gelatin Capsules Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 9: World Historic Review for Gelatin Capsules Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 10: World 13-Year Perspective for Gelatin Capsules Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 11: World Recent Past, Current & Future Analysis for Non-Gelatin Capsules Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 12: World Historic Review for Non-Gelatin Capsules Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 13: World 13-Year Perspective for Non-Gelatin Capsules Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 14: World Recent Past, Current & Future Analysis for Animal-based Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 15: World Historic Review for Animal-based Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 16: World 13-Year Perspective for Animal-based Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 17: World Recent Past, Current & Future Analysis for Plant & Fermentation-based Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 18: World Historic Review for Plant & Fermentation-based Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 19: World 13-Year Perspective for Plant & Fermentation-based Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 20: World Recent Past, Current & Future Analysis for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 21: World Historic Review for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 22: World 13-Year Perspective for Immediate-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 23: World Recent Past, Current & Future Analysis for Sustained / Extended-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 24: World Historic Review for Sustained / Extended-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 25: World 13-Year Perspective for Sustained / Extended-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 26: World Recent Past, Current & Future Analysis for Delayed / Enteric-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 27: World Historic Review for Delayed / Enteric-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 28: World 13-Year Perspective for Delayed / Enteric-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 29: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 30: World Historic Review for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 31: World 13-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 32: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 33: World Historic Review for Antibiotic & Antibacterial Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 34: World 13-Year Perspective for Antibiotic & Antibacterial Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 35: World Recent Past, Current & Future Analysis for Vitamins & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 36: World Historic Review for Vitamins & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 37: World 13-Year Perspective for Vitamins & Dietary Supplements Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 38: World Recent Past, Current & Future Analysis for Antacid & Antiflatulent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 39: World Historic Review for Antacid & Antiflatulent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 40: World 13-Year Perspective for Antacid & Antiflatulent Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 41: World Recent Past, Current & Future Analysis for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 42: World Historic Review for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 43: World 13-Year Perspective for Cardiovascular Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 44: World Recent Past, Current & Future Analysis for Pain Management & CNS Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 45: World Historic Review for Pain Management & CNS Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 46: World 13-Year Perspective for Pain Management & CNS Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 47: World Recent Past, Current & Future Analysis for Probiotics & Gut Health Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 48: World Historic Review for Probiotics & Gut Health Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 49: World 13-Year Perspective for Probiotics & Gut Health Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
TABLE 50: World Recent Past, Current & Future Analysis for Metabolic & Endocrine Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 51: World Historic Review for Metabolic & Endocrine Disorders Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 52: World 13-Year Perspective for Metabolic & Endocrine Disorders Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
TABLE 53: USA Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 54: USA Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 55: USA 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 56: USA Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 57: USA Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 58: USA 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 59: USA Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 60: USA Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 61: USA 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 62: USA Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 63: USA Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 64: USA 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
CANADA
TABLE 65: Canada Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 66: Canada Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 67: Canada 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 68: Canada Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 69: Canada Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 70: Canada 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 71: Canada Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 72: Canada Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 73: Canada 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 74: Canada Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 75: Canada Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 76: Canada 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
JAPAN
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
TABLE 77: Japan Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 78: Japan Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 79: Japan 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 80: Japan Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 81: Japan Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 82: Japan 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 83: Japan Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 84: Japan Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 85: Japan 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 86: Japan Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 87: Japan Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 88: Japan 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
CHINA
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
TABLE 89: China Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 90: China Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 91: China 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 92: China Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 93: China Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 94: China 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 95: China Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 96: China Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 97: China 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 98: China Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 99: China Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 100: China 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
EUROPE
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
TABLE 101: Europe Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 102: Europe Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 103: Europe 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 104: Europe Recent Past, Current & Future Analysis for Empty Capsules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
TABLE 105: Europe Historic Review for Empty Capsules by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 106: Europe 13-Year Perspective for Empty Capsules by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
TABLE 107: Europe Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 108: Europe Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 109: Europe 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 110: Europe Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 111: Europe Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 112: Europe 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 113: Europe Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 114: Europe Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 115: Europe 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
FRANCE
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
TABLE 116: France Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 117: France Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 118: France 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 119: France Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 120: France Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 121: France 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 122: France Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 123: France Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 124: France 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 125: France Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 126: France Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 127: France 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
GERMANY
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
TABLE 128: Germany Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 129: Germany Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 130: Germany 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 131: Germany Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 132: Germany Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 133: Germany 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 134: Germany Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 135: Germany Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 136: Germany 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 137: Germany Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 138: Germany Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 139: Germany 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
ITALY
TABLE 140: Italy Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 141: Italy Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 142: Italy 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 143: Italy Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 144: Italy Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 145: Italy 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 146: Italy Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 147: Italy Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 148: Italy 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 149: Italy Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 150: Italy Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 151: Italy 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
UNITED KINGDOM
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
TABLE 152: UK Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 153: UK Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 154: UK 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 155: UK Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 156: UK Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 157: UK 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 158: UK Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 159: UK Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 160: UK 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 161: UK Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 162: UK Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 163: UK 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
REST OF EUROPE
TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 165: Rest of Europe Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 166: Rest of Europe 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 168: Rest of Europe Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 169: Rest of Europe 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 171: Rest of Europe Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 172: Rest of Europe 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 174: Rest of Europe Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 175: Rest of Europe 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
ASIA-PACIFIC
Empty Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 177: Asia-Pacific Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 178: Asia-Pacific 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 180: Asia-Pacific Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 181: Asia-Pacific 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 183: Asia-Pacific Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 184: Asia-Pacific 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 186: Asia-Pacific Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 187: Asia-Pacific 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
REST OF WORLD
TABLE 188: Rest of World Recent Past, Current & Future Analysis for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 189: Rest of World Historic Review for Empty Capsules by Application - Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 190: Rest of World 13-Year Perspective for Empty Capsules by Application - Percentage Breakdown of Value Sales for Antibiotic & Antibacterial Application, Vitamins & Dietary Supplements Application, Antacid & Antiflatulent Application, Cardiovascular Therapy Application, Pain Management & CNS Application, Probiotics & Gut Health Application, Metabolic & Endocrine Disorders Application and Other Applications for the Years 2020, 2026 & 2032
TABLE 191: Rest of World Recent Past, Current & Future Analysis for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 192: Rest of World Historic Review for Empty Capsules by Product Type - Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 193: Rest of World 13-Year Perspective for Empty Capsules by Product Type - Percentage Breakdown of Value Sales for Gelatin Capsules Product Type and Non-Gelatin Capsules Product Type for the Years 2020, 2026 & 2032
TABLE 194: Rest of World Recent Past, Current & Future Analysis for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 195: Rest of World Historic Review for Empty Capsules by Source - Animal-based Source and Plant & Fermentation-based Source Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 196: Rest of World 13-Year Perspective for Empty Capsules by Source - Percentage Breakdown of Value Sales for Animal-based Source and Plant & Fermentation-based Source for the Years 2020, 2026 & 2032
TABLE 197: Rest of World Recent Past, Current & Future Analysis for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
TABLE 198: Rest of World Historic Review for Empty Capsules by Functionality - Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
TABLE 199: Rest of World 13-Year Perspective for Empty Capsules by Functionality - Percentage Breakdown of Value Sales for Immediate-Release Functionality, Sustained / Extended-Release Functionality, Delayed / Enteric-Release Functionality and Other Functionalities for the Years 2020, 2026 & 2032
IV. COMPETITION
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.